Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage biotechnology company focused on developing gene therapies for prevalent ocular diseases. Leveraging its proprietary intravitreal platform, Adverum aims to deliver durable, single-administration treatments that eliminate the need for frequent injections. The company's lead candidate, ixoberogene soroparvovec (Ixo-vec), targets neovascular and wet age-related macular degeneration with the goal of restoring vision and preventing blindness.
Adverum Biotechnologies, Inc. is looking for a Technical Development Scientist to join their team in Redwood City, CA. This person will design and execute experiments to support the development of gene therapy products, contribute to analytical method development, product characterization, and process optimization, and analyze and interpret complex scientific data.
Adverum Biotechnologies (NASDAQ: ADVM) is a clinical-stage biotechnology company focused on developing gene therapies for prevalent ocular diseases. Leveraging its proprietary intravitreal platform, Adverum aims to deliver durable, single-administration treatments that eliminate the need for frequent injections. The company's lead candidate, ixoberogene soroparvovec (Ixo-vec), targets neovascular and wet age-related macular degeneration with the goal of restoring vision and preventing blindness.
Adverum Biotechnologies, Inc.